WO2007019393A3 - Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties - Google Patents
Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties Download PDFInfo
- Publication number
- WO2007019393A3 WO2007019393A3 PCT/US2006/030622 US2006030622W WO2007019393A3 WO 2007019393 A3 WO2007019393 A3 WO 2007019393A3 US 2006030622 W US2006030622 W US 2006030622W WO 2007019393 A3 WO2007019393 A3 WO 2007019393A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dosage forms
- improved properties
- polymer blends
- providing improved
- osmotic dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Abstract
Disclosed are osmotic dosage forms including an osmotic core; a semi¬ permeable membrane that surrounds the osmotic core and comprises a blend of a cellulose acetate polymer and an acrylate copolymer; and an exit formed through the semi-permeable membrane. Also disclosed are methods of making and administering such dosage forms.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06789476A EP1912622A2 (en) | 2005-08-04 | 2006-08-04 | Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties |
JP2008525263A JP2009507774A (en) | 2005-08-04 | 2006-08-04 | Osmotic dosage form comprising a semi-permeable membrane with a polymer mixture providing improved properties |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70593405P | 2005-08-04 | 2005-08-04 | |
US60/705,934 | 2005-08-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007019393A2 WO2007019393A2 (en) | 2007-02-15 |
WO2007019393A3 true WO2007019393A3 (en) | 2007-05-31 |
Family
ID=37155365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/030622 WO2007019393A2 (en) | 2005-08-04 | 2006-08-04 | Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties |
Country Status (4)
Country | Link |
---|---|
US (1) | US20070031496A1 (en) |
EP (1) | EP1912622A2 (en) |
JP (1) | JP2009507774A (en) |
WO (1) | WO2007019393A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
US7538652B2 (en) * | 2006-08-29 | 2009-05-26 | International Business Machines Corporation | Electrical component tuned by conductive layer deletion |
US8518440B2 (en) | 2010-12-21 | 2013-08-27 | Confluent Surgical, Inc. | Biodegradable osmotic pump implant for drug delivery |
JP6041823B2 (en) | 2013-03-16 | 2016-12-14 | ファイザー・インク | Tofacitinib oral sustained release dosage form |
US11311488B2 (en) * | 2020-06-10 | 2022-04-26 | Auspex Pharmaceuticals, Inc. | Osmotic dosage forms comprising deutetrabenazine and methods of use thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4855141A (en) * | 1988-03-25 | 1989-08-08 | Alza Corporation | Device comprising means for protecting and dispensing fluid sensitive medicament |
US5595759A (en) * | 1994-11-10 | 1997-01-21 | Alza Corporation | Process for providing therapeutic composition |
WO2001051035A1 (en) * | 2000-01-14 | 2001-07-19 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
WO2004010981A1 (en) * | 2002-07-29 | 2004-02-05 | Alza Corporation | Methods and dosage forms for controlled delivery of paliperidone |
US20050287185A1 (en) * | 2004-06-23 | 2005-12-29 | David Wong | Extended release oxybutynin formulation |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2799241A (en) * | 1949-01-21 | 1957-07-16 | Wisconsin Alumni Res Found | Means for applying coatings to tablets or the like |
US3995631A (en) * | 1971-01-13 | 1976-12-07 | Alza Corporation | Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient |
US3865108A (en) * | 1971-05-17 | 1975-02-11 | Ortho Pharma Corp | Expandable drug delivery device |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4002173A (en) * | 1974-07-23 | 1977-01-11 | International Paper Company | Diester crosslinked polyglucan hydrogels and reticulated sponges thereof |
GB1478759A (en) * | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4008719A (en) * | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
US4207893A (en) * | 1977-08-29 | 1980-06-17 | Alza Corporation | Device using hydrophilic polymer for delivering drug to biological environment |
CH645391A5 (en) * | 1978-02-21 | 1984-09-28 | Ciba Geigy Ag | POLYMERS WITH SUCCINYLSBERSTEINSÄUREESTERESRESTE. |
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4519801A (en) * | 1982-07-12 | 1985-05-28 | Alza Corporation | Osmotic device with wall comprising cellulose ether and permeability enhancer |
US4578075A (en) * | 1982-12-20 | 1986-03-25 | Alza Corporation | Delivery system housing a plurality of delivery devices |
US4681583A (en) * | 1982-12-20 | 1987-07-21 | Alza Corporation | System for dispersing drug in biological environment |
US4612008A (en) * | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
US5082668A (en) * | 1983-05-11 | 1992-01-21 | Alza Corporation | Controlled-release system with constant pushing source |
US4783337A (en) * | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
US4863456A (en) * | 1986-04-30 | 1989-09-05 | Alza Corporation | Dosage form with improved delivery capability |
US5019379A (en) * | 1987-07-31 | 1991-05-28 | Massachusetts Institute Of Technology | Unsaturated polyanhydrides |
US5019397A (en) * | 1988-04-21 | 1991-05-28 | Alza Corporation | Aqueous emulsion for pharmaceutical dosage form |
US5160743A (en) * | 1988-04-28 | 1992-11-03 | Alza Corporation | Annealed composition for pharmaceutically acceptable drug |
US4931285A (en) * | 1988-04-28 | 1990-06-05 | Alza Corporation | Aqueous based pharmaceutical coating composition for dosage forms |
US5006346A (en) * | 1988-04-28 | 1991-04-09 | Alza Corporation | Delivery system |
US5024842A (en) * | 1988-04-28 | 1991-06-18 | Alza Corporation | Annealed coats |
US4902514A (en) * | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
US5091190A (en) * | 1989-09-05 | 1992-02-25 | Alza Corporation | Delivery system for administration blood-glucose lowering drug |
US5156850A (en) * | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
US5284662A (en) * | 1990-10-01 | 1994-02-08 | Ciba-Geigy Corp. | Oral osmotic system for slightly soluble active agents |
US5252338A (en) * | 1991-06-27 | 1993-10-12 | Alza Corporation | Therapy delayed |
US5190765A (en) * | 1991-06-27 | 1993-03-02 | Alza Corporation | Therapy delayed |
US5260068A (en) * | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
DE69425453T2 (en) * | 1993-04-23 | 2001-04-12 | Novartis Ag | Drug delivery device with controlled release |
HU213407B (en) * | 1993-12-09 | 1997-06-30 | Egyt Gyogyszervegyeszeti Gyar | Process for producing tablet with diffusive-osmotic release |
US5633011A (en) * | 1994-08-04 | 1997-05-27 | Alza Corporation | Progesterone replacement therapy |
US20030125714A1 (en) * | 2001-12-18 | 2003-07-03 | Edgren David Emil | Dosage form for time-varying patterns of drug delivery |
-
2006
- 2006-08-04 EP EP06789476A patent/EP1912622A2/en not_active Withdrawn
- 2006-08-04 JP JP2008525263A patent/JP2009507774A/en not_active Withdrawn
- 2006-08-04 US US11/499,008 patent/US20070031496A1/en not_active Abandoned
- 2006-08-04 WO PCT/US2006/030622 patent/WO2007019393A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4855141A (en) * | 1988-03-25 | 1989-08-08 | Alza Corporation | Device comprising means for protecting and dispensing fluid sensitive medicament |
US5595759A (en) * | 1994-11-10 | 1997-01-21 | Alza Corporation | Process for providing therapeutic composition |
WO2001051035A1 (en) * | 2000-01-14 | 2001-07-19 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
WO2004010981A1 (en) * | 2002-07-29 | 2004-02-05 | Alza Corporation | Methods and dosage forms for controlled delivery of paliperidone |
US20050287185A1 (en) * | 2004-06-23 | 2005-12-29 | David Wong | Extended release oxybutynin formulation |
Non-Patent Citations (1)
Title |
---|
JEDRAS Z: "ONE-COMPARTMENT GASTROINTESTINAL THERAPEUTIC SYSTEM FOR CHLORPROMAZINE HYDROCHLORIDE", ACTA PHARMACEUTICA JUGOSLAVICA, vol. 37, no. 2, 1987, pages 149 - 154, XP009081318, ISSN: 0001-6667 * |
Also Published As
Publication number | Publication date |
---|---|
US20070031496A1 (en) | 2007-02-08 |
JP2009507774A (en) | 2009-02-26 |
EP1912622A2 (en) | 2008-04-23 |
WO2007019393A2 (en) | 2007-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007019393A3 (en) | Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties | |
WO2008103599A3 (en) | Composition, its use in the preparation of membranes, and systems comprising the membranes | |
WO2006128620A3 (en) | Coupling for a multi-part dental implant system | |
WO2008093654A1 (en) | Hollow-fiber membrane and hollow-fiber-membrane module having the same included therein | |
WO2007135689A3 (en) | Membranes, coatings and films and methods for their preparation | |
WO2007127890A3 (en) | Structured films having acoustical absorbance properties | |
WO2007135193A3 (en) | Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means | |
BRPI0919266A2 (en) | device and method for transmitting an audio signal to a user, methods for manufacturing a device for transmitting an audio signal to the user, and for providing an audio device for a user, and device and method for transmitting a sound for a user. user having a tympanic membrane | |
EP2085443A4 (en) | Process for producing resin porous membrane with adhesive layer, resin porous membrane with adhesive layer, and filter member | |
WO2008022932A3 (en) | Controlled release system and method for manufacturing the same | |
WO2009151709A3 (en) | Spiral wound membrane module for forward osmotic use | |
DE602005001783D1 (en) | Hydrogen-permeable membrane and process for its preparation | |
SG135037A1 (en) | Composite semipermeable membrane, and production process thereof | |
ZA201007500B (en) | Improved method for making sulfonated block copolymers, method for making membranes from such block copolymers and membrane structures | |
GB2454385B (en) | Mixed matrix membranes with small pore molecular sieves and methods for making and using the membranes | |
EP1926544A4 (en) | Preparation method of polyamide thin film composite reverse osmosis membrane and polyamide thin film composite reverse osmosis membrane prepared therefrom | |
WO2011073796A3 (en) | Codon-optimzed hepatitis b virus core antigen (hbcag) | |
MY144159A (en) | Membrane post treatment | |
WO2008149440A1 (en) | Medicinal film preparation with rapidly dissolving property and flexibility | |
EP2144695A4 (en) | Modified porous membranes, methods of membrane pore modification, and methods of use thereof | |
SG131871A1 (en) | Ultrafiltration membranes and methods of making and use of ultrafiltration membranes | |
WO2008002905A3 (en) | Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same | |
WO2008063780A3 (en) | Vascular grafts with multiple channels and methods for making | |
WO2006044077A3 (en) | Controlled release composition with semi-permeable membrane and poloxamer flux enhancer | |
EP1907445A4 (en) | Polyamide reverse osmosis composite membrane and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2008525263 Country of ref document: JP Ref document number: 2006789476 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |